Literature DB >> 19006686

Molecular mechanisms of spinal cord dysfunction and cell death in the spinal hyperostotic mouse: implications for the pathophysiology of human cervical spondylotic myelopathy.

Wen-Ru Yu1, Darryl C Baptiste, Tianyi Liu, Ewa Odrobina, Greg J Stanisz, Michael G Fehlings.   

Abstract

Cervical spondylotic myelopathy (CSM) is the most common cause of spinal cord dysfunction in adults in Western society. Paradoxically, relatively little is known about the pathobiological mechanisms associated with the progressive loss of neural tissue in the spinal cord of CSM patients. In this report we have utilized the twy/twy mutant mouse, which develops ossification of the ligamentum flavum at C2-C3 and exhibits progressive paralysis. This animal model represents an excellent in vivo model of CSM. This study reports novel evidence, which demonstrates that chronic extrinsic cervical spinal cord compression leads to Fas-mediated apoptosis of neurons and oligodendrocytes which is associated with activation of caspase-8, -9 and -3 and progressive neurological deficits. While surgical decompression will remain the mainstay of management of CSM, molecular therapies, which target Fas-mediated apoptosis could show promise as a complementary approach to maximize neurological recovery in this common spinal cord condition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19006686     DOI: 10.1016/j.nbd.2008.09.024

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  25 in total

1.  Role of MK2 signaling pathway in the chronic compression of cervical spinal cord.

Authors:  Hongxing Song; Xiutong Fang; Mingjie Wen; Fang Yu; Kai Gao; Chenli Sun; Zhenwei Wang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

2.  Alteration in chondroitin sulfate proteoglycan expression at the epicenter of spinal cord is associated with the loss of behavioral function in Tiptoe walking Yoshimura mice.

Authors:  Jun Wang; Xiaofang Wang; Wei Rong; Jia Lv; Feng Wei; Zhongjun Liu
Journal:  Neurochem Res       Date:  2014-10-02       Impact factor: 3.996

Review 3.  Application of magnetic resonance imaging in cervical spondylotic myelopathy.

Authors:  Chuan Zhang; Sushant K Das; Dong-Jun Yang; Han-Feng Yang
Journal:  World J Radiol       Date:  2014-10-28

4.  The role of DTI in early detection of cervical spondylotic myelopathy: a preliminary study with 3-T MRI.

Authors:  Batuhan Kara; Azim Celik; Selhan Karadereler; Levent Ulusoy; Kursat Ganiyusufoglu; Levent Onat; Ayhan Mutlu; Ibrahim Ornek; Mustafa Sirvanci; Azmi Hamzaoglu
Journal:  Neuroradiology       Date:  2011-02-23       Impact factor: 2.804

5.  Posterior surgical treatment of cervical spondylotic myelopathy: review article.

Authors:  Paul D Kiely; John C Quinn; Jerry Y Du; Darren R Lebl
Journal:  HSS J       Date:  2015-02-10

6.  OLIGODENDROCYTE VULNERABILITY FOLLOWING TRAUMATIC BRAIN INJURY IN RATS: EFFECT OF MODERATE HYPOTHERMIA.

Authors:  George Lotocki; Juan de Rivero Vaccari; Ofelia Alonso; Juliana Sanchez Molano; Ryan Nixon; W Dalton Dietrich; Helen M Bramlett
Journal:  Ther Hypothermia Temp Manag       Date:  2011-04-05       Impact factor: 1.286

Review 7.  Advances in MR imaging for cervical spondylotic myelopathy.

Authors:  Benjamin M Ellingson; Noriko Salamon; Langston T Holly
Journal:  Eur Spine J       Date:  2013-08-06       Impact factor: 3.134

Review 8.  Trends, Challenges, and Opportunities Regarding Research in Non-traumatic Spinal Cord Dysfunction.

Authors:  Peter Wayne New; Sara J T Guilcher; Susan B Jaglal; Fin Biering-Sørensen; Vanessa K Noonan; Chester Ho
Journal:  Top Spinal Cord Inj Rehabil       Date:  2017

Review 9.  Pathobiology of cervical spondylotic myelopathy.

Authors:  Spyridon K Karadimas; Georgios Gatzounis; Michael G Fehlings
Journal:  Eur Spine J       Date:  2014-03-14       Impact factor: 3.134

Review 10.  Traumatic and nontraumatic spinal cord injury: pathological insights from neuroimaging.

Authors:  Gergely David; Siawoosh Mohammadi; Allan R Martin; Julien Cohen-Adad; Nikolaus Weiskopf; Alan Thompson; Patrick Freund
Journal:  Nat Rev Neurol       Date:  2019-10-31       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.